We previously isolated and characterized cDNA clones of DRT (EPHB2), encoding a receptor protein-tyrosine kinase of the EPH family. Northern blot analysis showed that EPHB2 transcripts are expressed in three sizes of approximately 4, 5, and 11 kb, suggesting that these transcripts are generated by alternative splicing and/or alternative use of polyadenylation sites. To explore this possibility, we isolated additional EPHB2 cDNA clones, including clone 5K-1, by re-screening the human fetal brain cDNA library. Nucleotide sequence analysis of clone 5K-1 revealed that it represents a variant transcript of EPHB2 (EPHB2v). Relative to the EPHB2 cDNA sequence previously reported, clone 5K-1 has two coding region deletions of 3 and 93 nucleotides. Nucleotide sequence analyses of EPHB2 genomic DNA fragments corresponding to these deletions suggest that the EPHB2v transcript is generated by alternative splicing. The 3' end of clone 5K-1 contains a polyadenosine stretch preceded by a potential polyadenylation signal, which is not used to generate the EPHB2 transcript. Taken together, these data indicate that EPHB2v is generated by both alternative splicing and alternative use of polyadenylation sites. The EPHB2v protein lacks one arginine residue that resides immediately following the EPHB2 transmembrane domain. In contrast, as a result of the frame shift caused by the 93 nucleotide deletion, the C-terminus of the EPHB2v protein is longer by 70 amino acids than that of EPHB2. We also show that the human neuroblastoma cell line SY5Y and NTera-2N neurons express high levels of EPHB2 and lower levels of EPHB2v. These structural variations found between the EPHB2 and EPHB2v proteins may re¯ect functional heterogeneity of EPHB2.
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Keywords: ephrin; functional diversity; neurodevelopment The EPH family is the largest subfamily of receptor protein-tyrosine kinase (PTK) genes. Several EPH family members have been shown to be expressed in temporally-and spatially-regulated fashion in the developing brain, suggesting that EPH-related PTKs play key roles in various developmental processes in the nervous system (Pandey et al., 1995; Tuzi and Gullick, 1994) . Recent studies have suggested that EPH-related PTKs and their ligands are involved in axon fasciculation, path®nding of speci®c axons, acquisition of brain subregional identities, and neuronal cell survival Cheng et al., 1995; Magal et al., 1996; Winslow et al., 1995) .
In addition to having 14 family members, PTK genes of the EPH family are known to generate variant transcripts which further increase the diversity of EPH family PTKs. Cek5+ and Cek5s are two variant transcripts of chicken EPHB2 (Cek5) and are shown to be generated by alternative splicing and by alternative use of polyadenylation signals, respectively (Connor and Pasquale, 1995) . Five variant transcripts have also been reported for rat EPHA5 (Ehk-1) (Maisonpierre et al., 1993; Taylor et al., 1994) , and a cDNA clone encoding a potential soluble form of Mek4 (EPHA3) has been isolated as well (Sajjadi et al., 1991) . With the exception of Cek5+ and Cek5s, mechanisms by which these variant transcripts of the EPH family are generated have not been investigated in detail.
We previously isolated and characterized cDNA clones of DRT, a member of the EPH gene family (Ikegaki et al., 1995) . According to the new nomenclature system recently proposed for EPHrelated PTKs and their ligands, DRT is now called EPHB2 (Eph Nomenclature Committee, 1997). Our previous studies have shown that EPHB2 is transcribed into three size transcripts of approximately 4, 5, and 11 kb suggesting that these EPHB2 transcripts are generated by alternative splicing and/or alternative use of polyadenylation sites.
To isolate additional cDNA clones of EPHB2, including ones representing possible variant transcripts of EPHB2, we re-screened the human fetal brain cDNA library using clone 31, representing the 5' end (*400 bp) of the EPHB2 cDNA, as a probe. From this screening, 26 clones positive for the EPHB2 probe were obtained. Preliminary nucleotide sequence analyses of these clones showed that clone 5K-1, approximately 4 kb in size, appeared to contain a complete coding region of EPHB2 as well as an adenosine stretch at the 3' end. Further analysis of the entire 5K-1 cDNA sequence has con®rmed that 5K-1 is a full-length EPHB2 cDNA clone that represents a variant transcript of EPHB2 or EPHB2v, encoding an isoform of EPHB2 (EPHB2v). Figure 1 shows the alignment of the EPHB2 and EPHB2v (clone 5K-1) nucleotide sequences. The two sequences share the same initiation codon, which is located at nucleotides 26 ± 28 of EPHB2v. Relative to EPHB2, EPHB2v has a deletion of three nucleotides (AAG), which resides two nucleotides downstream from the region corresponding to the transmembrane domain (nucleotides 1725 ± 1802 of EPHB2). As a result, relative to EPHB2, EPHB2v has a deletion of one arginine residue immediately juxtaposed to the Cterminus side of the transmembrane domain. EPHB2v has an additional deletion of 93 nucleotides relative to EPHB2 at the 3' end of its coding region. This 93 nucleotide deletion includes the stop codon previously reported for EPHB2 (clone FBK III 11c) and results in a frameshift. Consequently, the stop codon for EPHB2v (TAA) is relocated at nucleotides 3191 ± 3193 of the EPHB2v cDNA, which is 297 nucleotides Figure 1 Alignment of EPHB2 and EPHB2v nucleotide sequences. Identical nucleotides between EPHB2 and EPHB2v are shaded. Dashes (---) indicate nucleotides that are not present in the EPHB2 sequence. Nucleotides that are dierent between EPHB2 and EPHB2v due to polymorphism are marked by ®lled circles. The initiation codon, ATG, is indicated by a rectangle. Stop codons for EPHB2 (TGA) and EPHB2v (TAA) are also indicated by rectangles. The potential polyadenylation signal sequence (AATGAA) found in EPHB2v (nucleotides 3888 ± 3893 of the EPHB2v cDNA) is underlined. Three additional polyadenylation signals (AATAAA) found at the 3' untranslated region of EPHB2 are also underlined. The EPHB2 cDNA sequence was previously reported up to nucleotide 3768 (Ikegaki et al., 1995) . Figure 1 includes an additional nucleotide sequence (2375 bases) at the 3' untranslated region of clone FBK III 11c. Clone FBK III 11c contains nucleotides 428 ± 6143 of the EPHB2 cDNA. No adenosine stretch was identi®ed at the 3' end of clone FBK III 11c. The region corresponding to the transmembrane domain is marked by the broken line. The amino acid translation common to both EPHB2 and EPHB2v is shown above the nucleotide sequence, and the translation unique to EPHB2v is shown below the nucleotide sequence. The EcoRI cloning sites (GAATTC) are included in the EPHB2v cDNA sequence. The nucleotide sequence of EPHB2v has been deposited in the Genome Sequence Database under Accession No. AF025304. The human fetal brain cDNA expression library (Stratagene), which was previously used to isolate EPHB2 cDNA clones, was re-screened using a cDNA clone corresponding to the 5' end of EPHB2 as a probe. Hybridization was carried out in modi®ed Church buer (0.5 M sodium phosphate, 1 mM EDTA, 7% sodium dodecyl sulfate, 1% Ficoll, 1% polyvinylpyrrolidone, and 0.1% heparin, pH 7.2) at 658C overnight. Filters were washed in 26SSC (Standard Saline Citrate) containing 0.5% N-lauroylsarcosine at room temperature, followed by 0.16SSC containing 0.5% N-lauroylsarcosine at 658C. Filters were then analysed by autoradiography with exposures at 48C for 3 to 16 h. DNA sequencing was performed on both DNA strands by primer walking, and by the dideoxy chain termination method, using the Taq Dyedeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Inc), followed by analysis on an ABI 373A and 377 automated sequencers. Sequence information was analysed by GeneWorks 2.3.1 (Oxford Molecular) and MacVector 5.0.1 (Oxford Molecular) downstream from that of EPHB2. EPHB2v thus has additional 70 amino acids at the C-terminus compared to EPHB2. Overall, the EPHB2v protein is 69 amino acids longer than EPHB2.
Two single nucleotide changes between EPHB2v and EPHB2, which are likely due to sequence polymorphism, are also found at nucleotides 2979 and 3508 of the EPHB2 cDNA or the corresponding nucleotides 2897 and 3333 of the EPHB2v cDNA, respectively ( Figure  1 ). The change in the EPHB2v sequence at nucleotide 2897 results in a conservative amino acid change from leucine (in EPHB2) to valine (in EPHB2v).
An adenosine stretch was found at the 3' end of EPHB2v (nucleotides 3913 ± 3949, Figure 1 ). Preceding to this adenosine stretch, a potential polyadenylation sequence (AATGAA) was also identi®ed (nucleotides 3888 ± 3893, Figure 1) , which matches ®ve out of six residues of the polyadenylation consensus sequence (AATAAA) (Proudfoot, 1982; Proudfoot and Brownlee, 1976) . In contrast, clone FBK III 11c (shown in Figure 1 as EPHB2 cDNA) contains one potential polyadenylation signal (AATGAA) at nucleotides 3888 ± 3893 (used for EPHB2v transcripts) and three additional polyadenylation signals (AATAAA) at nucelotides 4835 ± 4840, 5260 ± 5265, and 5756 ± 5761. Apparently, none of these four polyadenylation signals were used to generate EPHB2 transcripts represented by clone FBK III 11c as it contains no 3' adenosine stretch.
To investigate possible mechanisms that account for the internal deletions found in the EPHB2v transcript, we analysed the nucleotide sequence of EPHB2 genomic DNA fragments encompassing these deletions. Polymerase chain reaction (PCR) was carried out to amplify the DNA fragment encompassing the three nucleotide deletion found in EPHB2v using a P1 clone containing the EPHB2 gene as a template. The EPHB2 cDNA (clone FBK III 11c) was used as control. As shown in Figure 2a , the EPHB2 genomic DNA gave rise to a PCR product larger in size than that derived from the EPHB2 cDNA, indicating that the EPHB2 genomic DNA contains intron(s) in this region. Nucleotide sequence analysis of the EPHB2 genomic DNA fragment has con®rmed the presence of one intron in this region. The nucleotide sequence at these exon/intron boundaries is shown in Figure 2b . Comparison of these EPHB2 exon/intron boundaries to the consensus splicing junction sequences (Mount, 1982) illustrates that the three nucleotide deletion found in EPHB2v is likely to be due to alternative splicing.
A similar analysis was carried out on the region corresponding to the 93 nucleotide deletion in EPHB2v. DNA fragments that encompass this region were generated by PCR using a P1 clone containing the EPHB2 gene, the EPHB2 cDNA (clone FBK III 11c), and the EPHB2v cDNA (clone 5K-1) as templates. As shown in Figure 3a , PCR products derived from the EPHB2 P1 DNA and the EPHB2 cDNA have the same size, whereas the PCR product derived from the EPHB2v cDNA is smaller in size. Nucleotide sequence analysis of the EPHB2 genomic DNA in this region has con®rmed that it has the same sequence as the EPHB2 cDNA. These data, thus, suggest that these 93 nucleotides were processed as an intron for EPHB2v. In fact, the splicing consensus sequences are identi®ed at the boundaries of this deletion (Figure 3b) . Taken together, EPHB2v transcripts represented by clone 5K-1 are generated by both alternative splicing and alternative use of polyadenylation signals.
Since the neuroblastoma cell line SY5Y and NTera-2N neurons express high levels of the 4, 5, and 11 kb EPHB2 transcripts (Ikegaki et al., 1995) , we examined whether both EPHB2 and EPHB2v transcripts are a b Figure 2 The three nucleotide deletion in EPHB2v, relative to EPHB2, is due to alternative splicing. (a) DNA fragments encompassing the three nucleotide deletion in EPHB2v, were ampli®ed by PCR using a P1 clone containing the EPHB2 gene and the EPHB2 cDNA (clone FBK III 11c) as templates. PCR primers correspond to nucleotides 1650 ± 1669 and 1758 ± 1777 of the EPHB2v cDNA sequence (Figure 1) . The DNA fragment derived from the EPHB2 genomic clone was sequenced to determine the exon-intron boundaries. (b) Schematic representation of the result. The consensus sequence at exon-intron boundaries is shown as the reference. Nucleotides that are absolutely conserved at the splicing junctions are underlined. PCR ampli®cations were in volumes of 10 ml and contained 0.4 mM primers, 0.2 mM dNTPs, the high salt buer for PCR using Taq Extender (Stratagene) 0.5 unit of Taq polymerase (Perkin-Elmer), and a P1 DNA clone containing EPHB2 as a template. Taq start antibody (Clontech), Perfect Match (Stratagene), and Taq Extender (Stratagene) were also included in the PCR. PCR conditions were 948C for 3 min, followed by 15 cycles of 948C for 1 min, 708C for 10 min with a 0.78C decrease per cycle, and an additional 25 cycles of 948C for 1 min, 558C for 45 s, and 728C for 10 min, and by 20 min for extension at 728C. PCR products were analysed in Visigel (Stratagene), stained with ethidium bromide, and visualized under UV light present in these cell lines. First, we employed heteroduplex analysis to investigate whether EPHB2 transcripts with and without the three nucleotide deletion were expressed in these cells. cDNA fragments encompassing the three nucleotide deletion unique to EPHB2v were ®rst ampli®ed by reverse transcription-polymerase chain reaction (RT ± PCR). The resulting PCR products were then subjected to the heteroduplex analysis. As shown in Figure 4a , PCR products derived from SY5Y, NTera-2N, and an equal mixture of PCR products derived from the EPHB2 cDNA and the EPHB2v cDNA demonstrate heteroduplexed DNAs in addition to the homoduplexed DNAs. In contrast, only homoduplexed DNA bands were identi®ed in PCR products derived from the EPHB2 and EPHB2v cDNAs. These data show that both EPHB2 and EPHB2v transcripts are expressed in these cell lines.
To examine whether EPHB2v transcripts with the 93 nucleotide deletion are expressed in the cell, we ampli®ed cDNA fragments encompassing the 93 nucleotide deletion from SY5Y and NTera-2N. As shown in Figure 4b , both DNA fragments derived from EPHB2 (310 bp) and EPHB2v (217 bp) were detected in SY5Y and NTera-2N. However, the EPHB2v form with the 93 nucleotide deletion is expressed at lower levels compared to the the EPHB2 form, suggesting either that the region alternatively spliced in EPHB2v transcripts aects the overall RNA stability or that the eciency of splicing at this intron is low. These data also suggest that the EPHB2v transcript with the 93 nucleotide deletion represents a minor EPHB2 transcript with approximately 4 kb in size, but not the major 4 kb EPHB2 transcript detected by Northern blot analysis (Ikegaki et al., 1995) . Instead, the two major EPHB2 transcripts of 4 kb and 5 kb may be generated by alternative use of polyadenylation signals as clone FBK III 11c contains three additional polyadenylation signals in its 3' untranslated region.
All variations found in EPHB2v are located downstream of the transmembrane domain, and the extracellular region of EPHB2v is identical to that of EPHB2. This suggests that these two isoforms bind to the same ligands but their downstream signaling is altered as they interact with dierent signal transduction eectors. Our study and others (Connor and Pasquale, 1995) led to the suggestion that alternative splicing and alternative use of polyadenylation signals potentially diversify the function of EPH-related PTKs. Since RET, another receptor protein-tyrosine kinase gene expressed preferentially in the nervous system encodes two isoforms with dierent C-termini by alternative polyadenylation and splicing of mRNA a b Figure 3 The 93 nucleotide deletion in EPHB2v, relative to EPHB2, is due to alternative splicing. (a) PCR ampli®ction of DNA segments corresponding to the 93 nucleotide deletion in EPHB2v was performed using a P1 clone containing the EPHB2 gene, the EPHB2 cDNA (clone FBK III 11c), and the EPHB2v cDNA (clone 5K-1) as templates. PCR primers correspond to nucleotides 2952 ± 2971 and 3036 ± 3055 of the EPHB2v cDNA sequence (Figure 1 ). The DNA fragment derived from the EPHB2 genomic clone was sequenced and found to have the same nucleotide sequence as that derived from the EPHB2 cDNA. (b) The nucleotide sequence at the boundaries of the 93 nucleotide deletion contains the splicing junction consensus sequences. PCR conditions used are the same as in Figure 2 ( Tahira et al., 1990) , these mechanisms may serve as an eective way to increase functional diversities of PTKs expressed in the nervous system. Figure 4 EPHB2 and EPHB2v transcripts are both expressed in human SY5Y and NTera-2N cells. (a) Heteroduplex analysis was performed to examine the existence of EPHB2 transcripts with the three nucleotide deletion unique to EPHB2v in SY5Y and NTera-2N cells. RT ± PCR was ®rst performed using total RNA prepared from SY5Y and NTera-2N cells. Controls were PCR products derived from the EPHB2v cDNA (clone 5K-1), the EPHB2 cDNA (clone FBK III 11c) and an equal mixture of PCR products derived from EPHB2 cDNA and EPHB2v cDNA. The PCR products were then subjected to heteroduplex analysis. The PCR primers used correspond to nucleotides 1597 ± 1616 and 1893 ± 1912 of the EPHB2v cDNA (Figure 1 ). (b) RT ± PCR was performed to examine the existence of EPHB2 transcripts with the 93 nucleotide deletion unique to EPHB2v using total RNA prepared from SY5Y and NTera-2N as substrates. The EPHB2v cDNA (clone 5K-1) and the EPHB2 cDNA (clone FBK III 11c) were used as controls. The PCR primers used correspond to nucleotides 2839 ± 2858 and 3036 ± 3055 of the EPHB2v cDNA ( Figure  1 ). Each RT reaction was in a volume of 30 ml and contained 2 mg of total RNA, 35 ng random hexamer, 250 ng oligo dT (15 mer), 10 mM DTT, 500 mM dNTPs, 1 unit PRIME RNase inhibitor (3 PRIME 745 PRIME, Inc), and 200 units of Superscript II reverse transcriptase (Life Technologies). The reverse transcription process was allowed to take place under the conditions of 258C for 10 min with 18C increase per 20 s, and 558C for 60 min. One-®fteenth of the reverse transcription reaction, or 10 nanograms of the cDNA controls, were subjected to PCR ampli®cation. The PCR ampli®cation procedure was the same as that used to amplify the EPHB2 genomic DNA (Figure 2 ). For heteroduplex analysis, the PCR products were heat denatured at 958C for 8 min, followed by 10 1 min incubation at 908C with 108C decrease for each incubation. DNA samples were subjected to 10% polyacrylamide gel electrophoresis containing 10% glycerol in TBE buer (89 mM Tris, 80 mM borate, 1 mM EDTA) at 48C. The buer was recirculated during electrophoresis, which was run at 200 V, 23 mA for 10 min; at 180 V, 19 mA for 1 h, and at 125 V, 17 mA for 22 h (Xing et al., 1996) . The gel was stained with ethidium bromide (0.5 mg/ml) and DNA bands were visualized under UV light a b
